Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: analysis of 1806 cases. - Gatalica Z; Millis SZ; Vranic S; Bender R; Basu GD; Voss A; Von Hoff DD (Oncotarget, 2014)